Dose variation due to change in planned position for patients with carcinoma of the cervix undergoing high-dose-rate brachytherapy- 2D dose analysis
Purpose: To assess the dosimetry to organs at risk (OARs) in lithotomy position with a planned time-dose pattern obtained from supine position.
Methods: The sample consists of thirty patients with carcinoma of the uterine cervix, Stage II and III. Patients often feel discomfort in supine position (S position) when compared to lithotomy position (M position) due to relaxation of pelvic floor muscles after the insertion of applicator (tandem and ovoids) or before delivery of the treatment. Each patient was imaged with orthogonal X- ray radiographs simultaneously in two positions, i.e. S position and M position. Dwell time and dwell position pattern obtained from the optimized plan in S position was used to generate plan in M position. Following dose reference points (point A, pelvic wall points, bladder points, rectal, anorectum (AR point) and rectosigmoid (RS point) points) were identified for analysis in S and M positions. The dosimetric data for reference points generated by the Brachyvision TPS was analyzed.
Results: Pelvic wall points registered lower doses in M position when compared to S position. Mean doses for right pelvic wall point (RPW) and left pelvic wall point (LPW) were reduced by -10.02 % and -11.5% in M position, respectively. International Commission on Radiation Units and Measurements (ICRU) bladder point also registered lower doses in M position with a mean dose of -6.8%. Rectal point showed dose reduction by mean of -6.4%. AR and RS points showed an increased dose in M position by a mean of 16.5% and 10%, respectively.
Conclusion: Current dosimetry procedure serves as a model with time-dose pattern planned for S position, but delivered in M position, without dose optimization. Prioritization of comfort and position can be considered in conjunction with optimization of dose.
Atahan IL, Onal C, Ozyar E, et al. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer 2007; 17:833-42.
Nag S, Cardenes H, Chang S, et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 2004; 60:1160-72.
Nag S. High dose rate brachytherapy: its clinical applications and treatment guidelines. Technol Cancer Res Treat 2004; 3:269-87.
Viani GA, Manta GB, Stefano EJ, de Fendi LI. Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials. J Exp Clin Cancer Res 2009; 28:47.
Fu KK, Phillips TL. High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1990; 19:791-6.
Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote after loading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991; 21:1425-34.
Petereit DG, Sarkaria JN, Potter DM, Schink JC. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. Int J Radiat Oncol Biol Phys 1999; 45:1267-74.
Sarkaria JN, Petereit DG, Stitt JA, et al. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 1994; 30:75-82.
Garipağaoğlu M, Tunçel N, Dalmaz Mg, et al. Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy. Br J Radiol 2006; 79:504-9.
Hoskin PJ, Cook M, Bouscale D, Cansdale J. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy. Radiother Oncol 1996; 40:59-62.
Kim RY, Meyer JT, Plott WE, et al. Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: frequency and types of variation. Radiology 1995; 195:419-22.
Datta NR, Kumar S, Das KJ, et al. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38. Radiother Oncol 2001; 60:15-24.
Grigsby PW, Georgiou A, Williamson JF, Perez CA. Anatomic variation of gynecologic brachytherapy prescription points. Int J Radiat Oncol Biol Phys 1993; 27:725-9.
Nag S, Erickson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48:201-11.
Wulf J, Popp K, Oppitz U, et al. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions. Strahlenther Onkol 2004; 180:216-24.
Mobit P, Baird MC, Kanakamedala MR, et al. 3D image-based customized treatment planning versus standard plans for cervix cancer HDR brachytherapy. Int J Radiat Oncol Biol Phys 2010; 78: S408.
Kolkman-Deurloo IK, Nuyttens JJ, Hanssens PE, Levendag PC. Intraoperative HDR brachytherapy for rectal cancer using a flexible intraoperative template: standard plans versus individual planning. Radiother Oncol 2004; 70:75-9.
Callan JR, Kelly RT, Quinn ML, et al. Human factors evaluation of remote after loading brchytherpay. United States Nuclear Regulatory Commission, NUREG/CR-6125, Washington D C, 1995; 1.
Hellebust TP, Dale E, Skjønsberg A, Olsen DR. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 2001; 60:273-80.
Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU Report No 38. 1985.
Bayley AJ, Catton CN, Haycocks T, et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 2004; 70:37-44.
Pergolizzi S, Settineri N, Ascenti G, et al. Enlarged axillary nodes and position of the arms in axillary irradiation--a computed tomography and magnetic resonance imaging evaluation. Acta Oncol 2004; 43:182-5.
Pergolizzi S, Settineri N, Gaeta M, et al. What is the best position of the arms in mantle field for Hodgkin's disease? Int J Radiat Oncol Biol Phys 2000; 46:119-22.
Joelsson I, Bäckström A. Dose rate measurements in bladder and rectum. Intracavitary radiation of carcinoma of the uterine cervix. Acta Radiol Ther Phys Biol 1969; 8:343-59.
Joelsson I, Bäckström A. Applicators for remote afterloading technique for optimum pelvic dose distribution in carcinoma of the uterine cervix. Acta Radiol Ther Phys Biol 1970; 9:233-46.
Yun HG, Shin KC. Study of patient's position to reduce late complications in high dose rate intracavitary radiation of the uterine cervix cancer. J Korean Soc Ther Radiol Oncol 1998; 16: 477-84.
Talluri AK, Alluri KR, Gudipudi DK, et al. Study of positional dependence of dose to bladder, pelvic wall and rectal points in High-Dose-Rate Brachytherapy in cervical cancer patients. J Med Phys 2013; 38:178-84.
Meng J, Yewondwossen M. Rationality and evidence of pre-prepared treatment plan in Oesophageal HDR brachytherapy. Int J Med Health Pharmaceutical and Biomed Eng 2013; 7: 464-6.
Bahena JH, Martinez A, Yan D, et al. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator. Int J Radiat Oncol Biol Phys 1998; 41:13-9.
Ebruli C, Demiral AN, Cetingöz R, et al. The variability of applicator position among high dose rate intracavitary brachytherapy applications in cervical cancer patients treated with ring & tandem applicators. Tumori 2007; 93:432-8.
Elhanafy OA, Das RK, Paliwal BR, et al. Anatomic variation of prescription points and treatment volume with fractionated high-dose rate gynecological brachytherapy. J Appl Clin Med Phys 2002; 3:1-5.
Hoskin PJ, Bownes P, Summers A. The influence of applicator angle on dosimetry in vaginal vault brachytherapy. Br J Radiol 2002; 75:234-7.
Iatì G, Pontoriero A, Mondello S, et al. Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position. Brachytherapy 2014; 13:568-71.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.